Articles

This Super Bowl, the game to watch is prediction markets versus sportsbooks

If you’re risking money on the big game, one of these methods could be a surprising tax win.

‘I’m not made of money’: My heating engineer didn’t fix my radiators on his first visit. Do I pay him a second time?

“He charged $180 for the second visit for his time, including $40 for the part.”

After bitcoin’s fall, pity those wildly enthusiastic investors who borrowed billions against crypto

The speculation that bitcoin would hit $200,000 in 2025 now seems like a dream. Because it was.

‘Guests tell me I have dust bunnies’: My $150-an-hour cleaner has become increasingly negligent. Do I fire her?

”I like her as a friend, but I’m underwhelmed as a client.”

There is a severe doctor shortage. How to find a good one.

What can you do if your doctor retires or quits?

Getting a doctor’s appointment will become even harder as a perfect storm hits the U.S. healthcare system

Healthcare costs are going up across the board, and fewer people are properly insured — or insured at all.

The NFL heads into the Super Bowl after a season of record ratings. That could make games cost more to watch in the future.

The NFL hopes that Sunday’s Super Bowl LX between the Seattle Seahawks and New England Patriots will top last year’s record TV ratings, after a season in which the league notched its highest ratings in 36 years.

Investors are asking if they need to own gold and silver at all

Precious metals may be done falling — but they’re not done being tested.

This year’s Super Bowl ads are telling you the AI bubble is about to burst

Why the artificial-intelligence advertising spree could be the last hurrah — like the dot-coms in 2000.

Jeep maker Stellantis facing worst-ever stock rout as it takes $26 billion hit over miscalculating EV demand

Shares of Stellantis are headed for their worst-ever day of trading after the carmaker announced a massive charge to reset its business.

Novo Nordisk stock climbs out of hole on FDA chief’s threat to block Hims and Hers pill

Novo Nordisk shares rallied on Friday in what’s still been a painful week as the Food and Drug Administration may weigh in on the side of the Danish drugmaker in its dispute over a copycat drug.

A tech wreck has rattled markets. Why this battered S&P 500 sector could be primed for a bounce.

A popular software ETF is now at extremely oversold levels, according to one measure
1 31 32 33 34 35 2,428